Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Kong, Fanjun ^a,b   Liu, Jie ^c   Liu, Yongheng ^d   Song, Bao ^c   Wang, Hualing ^b   Liu, Wenchao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 456 Hospital of Chinese PLA   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; DNA; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953548259     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-72     Document Type: Article

References (28)

1. Patterns of cancer incidence, mortality, and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world. F Kamangar GM Dores WF Anderson, J Clin Oncol 2006 24 14 2137 2150 10.1200/JCO.2005.05.2308 16682732
2. Cytokines in cancer immunity and immunotherapy. MJ Smyth E Cretney MH Kershaw Y Hayakawa, Immunol Rev 2004 202 275 293 10.1111/j.0105-2896.2004.00199. x 15546400
3. The multifaceted relationship between IL-10 and adaptive immunity:putting together the pieces of a puzzle. S Mocellin F Marincola CR Rossi D Nitti M Lise, Cytokine Growth Factor.Rev 2004 15 61 76 10.1016/j.cytogfr.2003.11.001 14746814
4. An investigation of polymorphism in the interleukin-10 gene promoter. DM Turner DM Williams D Sankaran M Lazzarus PJ Sinnott IV Hutchinson, Eur J Immunogenet 1997 24 1 8 9043871
5. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. AW Gibson JC Edberg J Wu RG Westendorp TW Huizinga RP Kimberly, J Immunol 2001 166 3915 3922 11238636
6. Interleukin-10 and the immune response against cancer: a counterpoint. S Mocellin FM Marincola HA Young, J Leukoc Biol 2005 78 1043 1051 10.1189/jlb.0705358 16204623
7. Interleukin 10 pretreatment protects target cells from tumor- and allospecific cytotoxic T cells and downregulates HLA class I expression. M Matsuda F Salazar M Petersson G Masucci J Hansson P Pisa, J Exp Med 1994 180 2371 2376 10.1084/jem.180.6.2371 7964510
8. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. JM Kim CI Brannan NG Copeland, J Immunol 1992 148 3618 3623 1350294
9. Mapping of the human IL10 gene and further characterization of the 5'flanking sequence. J Eskdale D Kube H Tesch, Immunogenetics 1997 46 120 128 10.1007/s002510050250 9162098
10. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. K Kingo R Ratsep S Koks M Karelson H Silm E Vasar, J Dermatol Sci 2005 37 111 113 10.1016/j.jdermsci.2004.10.002 15659329
11. Polymorphic haplotypes of the interleukin-10 5'flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo, Arthritis Rheum 1999 42 1101 1108 10.1002/1529- 0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y 10366102
12. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. SC Hoffmann EM Stanley E Cox Darrin N Craighead BS DiMercurio DE Koziol DM Harlan AD Kirk PJ Blair, Transplantation 2001 72 1444 1450 10.1097/00007890-200110270-00019 11685118
13. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. WM Howell MJ Rose-Zerilli, J Nutr 2007 137 1 Suppl 194S 199S 17182825
14. A rapid procedure for extracting genomic DNA from leukocytes. SW John G Weitzner R Rozen CR Scriver, Nucleic Acids Res 1991 19 408 10.1093/nar/19.2.408 2014181
15. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. CM Shih YL Lee HL Chiou, Lung Cancer 2005 50 3 291 297 10.1016/j.lungcan.2005.07.007 16122836
16. Interleukin- 10 polymorphisms, cancer susceptibility and prognosis. WM Howell MJ Rose-Zerilli, Fam Cancer 2006 5 2 143 149 10.1007/s10689-005-0072-3 16736283
17. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. KC Smith AC Bateman HM Fussell WM Howell, Eur J Immunogenet 2004 31 167 173 10.1111/j.1365-2370.2004.00462.x 15265021
18. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. SP Balasubramanian IA Azmy SE Higham, BMC Cancer 2006 6 188 10.1186/1471-2407-6-188 16842617
19. Interleukin- 10 promoter polymorphism is associated with decreased breast cancer risk. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder H Koppel TC Wascher B Paulweber H Samonigg, Breast Cancer Res Treat 2005 90 113 5 10.1007/s10549-004-3607-7 15803357
20. Polymorphisms of Interleukin-10 and tumour necrosis factor- gene promoter and breast cancer risk. L Giordani P Bruzzi C Lasalandra M Quaranta F Schittulli F Ragione Della A Iolascon, Clin Chem 2003 49 1664 1667 10.1373/49.10.1664 14500594
21. Frequency of cytokinepolymor phisms in populations from western Europe, Africa, Asia, the Middle East and South America. A Meenagh F Willians OA Ross, Human Immunol 2002 63 1055 1061 10.1016/S0198-8859(02)00440-8 (Pubitemid 35231690)
22. Interleukin- 10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomeruloselerosis in Korea. HJ Chin KY Na SJ Kim, J Korean Med Sci 2005 20 6 989 993 10.3346/jkms.2005.20.6.989 16361810
23. Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. R Alonso A Suarez P Castro AJ Lacave C Gutierrez, Melanoma Res 2005 15 53 60 10.1097/00008390-200502000-00009 15714121
24. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. C Scassellati R Zanardini R Squitti, Neurosci Lett 2004 35 119 122 10.1016/j.neulet.2003.11.033 (Pubitemid 38121483)
25. Allelle frequencies of polymorphisms of TNF, IL-6, IL-10 and IFN G in an Italian Caucasian population. F Poli A Nocco S Berra, Eur J Immunogrnet 2002 29 3 237 240 10.1046/j.1365-2370.2002.00303.x (Pubitemid 34621798)
26. IL- 10 haplotypes as possible predictors of spontaneous clearance of HCV infection. A Mangia R Santoro M Piattelli, Cytokine 2004 25 103 109 10.1016/j.cyto.2003.10.005 14698136
27. A polymorphic dinucleotide repeat in the human IL-10 promoter. J Eskdale Gallagher, Immunogenetics 1995 42 444 445 10.1007/BF00179416 7590988
28. Association of interleukin-10 gene variation with breast cancer prognosis. A Gerger W Renner T Langsenlehner G Hofmann G Knechtel J Szkandera H Samonigg P Krippl U Langsenlehner, Breast Cancer Res Treat 2010 119 701 705 10.1007/s10549-009-0417-y 19437115